Target Name: RNU6-651P
NCBI ID: G106479855
Other Name(s): RNA, U6 small nuclear 651, pseudogene

Unraveling the Potential of RNU6-651P as a Drug Target or Biomarker

Introduction

RNA-uracil nucleotide (RNA-U) is an important intracellular molecule and plays a key role in biological processes such as gene expression regulation and RNA splicing. Among them, U6 small nuclear RNA (U6-snRNA) has broad application prospects in cells due to its stability, variability and expression regulation properties. In recent years, studies have found that U6-snRNA plays an important role in many diseases, such as tumors, neurodegenerative diseases, etc. Therefore, studying the biological function of RNA-U651P (RNA, U6 small nuclear 651, pseudogene) has important theoretical significance and practical value.

Biological functions of RNA-U651P

RNA-U651P is an RNA molecule with a length of 29.1 nucleotides, and its coding region contains a conserved amino acid sequence. The functions of RNA-U651P in cells are mainly reflected in the following aspects:

1. Participate in the composition of RNA-binding proteins (RBP)

RNA-U651P is an important component of RBP subunit RNA (RBP-RNA). It can bind to RBP and thereby participate in the composition of RNA-binding proteins. RBP is a complex protein composed of multiple subunits, of which RBP1 and RBP2 are mainly encoded by RNA-U651P. By binding to RNA-U651P, RBP can recognize and bind to various RNA molecules in cells, thereby participating in the regulation of gene expression.

2. Regulate RNA splicing

RNA-U651P also participates in the RNA splicing process in cells. RNA splicing means that after transcription, RNA molecules remove introns and form mature mRNA through the action of RNA splicing enzymes. RNA-U651P can affect the stability and efficiency of RNA splicing by binding to RBP. Studies have found that the deletion of RNA-U651P can lead to abnormal RNA splicing, thereby affecting gene expression.

3. Participate in RNA modification

RNA-U651P is also involved in the RNA modification process in cells. RNA modification refers to various chemical modifications that occur on RNA molecules, such as phosphorylation, methylation, etc. RNA-U651P can participate in the process of RNA modification by binding to RNA-CBP2. In addition, RNA-U651P can also bind to RNA-A12 and participate in the modification process of RNA modification.

4. Participate in the degradation of RNA-binding proteins

RNA-U651P is also involved in the degradation process of RNA-binding proteins in cells. RNA-binding proteins are complex proteins composed of multiple subunits that participate in the regulation of gene expression by binding to RNA molecules. RNA-U651P can bind to RNA-BP1 and thereby degrade RNA-BP1, thereby affecting the stability of RNA-binding proteins.

Pharmacological significance of RNA-U651P

RNA-U651P has a variety of biological functions in cells, which provides a theoretical basis for studying the pharmacological significance of RNA-U651P. In recent years, researchers have discovered through in vitro and in vivo experiments that RNA-U651P has good anti-tumor and anti-neurodegenerative disease effects.

1. Anti-tumor effect

Research shows that RNA-U651P has good anti-tumor effects. The expression level of RNA-U651P is higher in tumor cells, while the expression level of RNA-U651P is lower in normal cells. By administering RNA-U651P, the growth rate of tumor cells can be reduced and the invasion and metastasis of tumor cells can be inhibited.

2. Anti-neurodegenerative disease effect

RNA-U651P also plays an important role in neurodegenerative diseases. For example, RNA-U651P can bind to proteins associated with neurodegenerative diseases, thereby affecting the activity of these proteins. In addition, RNA-U651P can also participate in the apoptosis of nerve cells by regulating RNA expression in nerve cells, which may play a therapeutic role in neurodegenerative diseases.

3. Neuroprotective effect

RNA-U651P also plays an important role in neuroprotection. RNA-U651P can bind to neuroprotection-related proteins and thereby participate in the regulation of neuroprotection mechanisms. Study finds that loss of RNA-U651P leads to loss of neuroprotective mechanisms, thereby exacerbating neurodegenerative diseases

Protein Name: RNA, U6 Small Nuclear 651, Pseudogene

More Common Targets

RNU6-667P | RNU6-673P | RNU6-696P | RNU6-69P | RNU6-6P | RNU6-702P | RNU6-705P | RNU6-716P | RNU6-719P | RNU6-732P | RNU6-735P | RNU6-737P | RNU6-747P | RNU6-76P | RNU6-778P | RNU6-785P | RNU6-791P | RNU6-795P | RNU6-79P | RNU6-808P | RNU6-809P | RNU6-81P | RNU6-826P | RNU6-833P | RNU6-83P | RNU6-850P | RNU6-876P | RNU6-893P | RNU6-900P | RNU6-901P | RNU6-90P | RNU6-919P | RNU6-947P | RNU6-951P | RNU6-968P | RNU6-98P | RNU6-990P | RNU6ATAC | RNU6ATAC18P | RNU6V | RNU7-1 | RNU7-102P | RNU7-11P | RNU7-13P | RNU7-156P | RNU7-16P | RNU7-180P | RNU7-26P | RNU7-2P | RNU7-34P | RNU7-35P | RNU7-45P | RNU7-57P | RNU7-61P | RNU7-72P | RNU7-76P | RNVU1-1 | RNVU1-18 | RNVU1-19 | RNVU1-20 | RNVU1-7 | RNY1 | RNY3 | RNY3P3 | RNY4 | RNY4P10 | RNY4P13 | RNY4P18 | RNY4P19 | RNY4P20 | RNY4P25 | RNY5 | RNY5P5 | RO60 | ROBO1 | ROBO2 | ROBO3 | ROBO4 | ROCK1 | ROCK1P1 | ROCK2 | ROCR | Rod cGMP phosphodiesterase 6 | ROGDI | ROM1 | ROMO1 | ROPN1 | ROPN1B | ROPN1L | ROR1 | ROR1-AS1 | ROR2 | RORA | RORA-AS1 | RORB | RORC | ROS1 | Roundabout homolog receptor | RP1 | RP1L1